Alexandria Company for Pharmaceuticals and Chemical Industries (AXPH) Key Statistics
19 reported figures for Alexandria Company for Pharmaceuticals and Chemical Industries — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 8.32B
- Dividend yield
- 3.78%
Income (latest fiscal year)
- Revenue
- EGP 1.02B
- Net income
- EGP 173.83M
- EBITDA
- EGP 248.14M
- Free cash flow
- EGP 77.44M
Balance sheet
- Total assets
- EGP 805.28M
- Total debt
- EGP 7.84M
Growth
- Revenue growth
- 23.52%
- Profit growth
- 54.04%
- EPS growth
- 54.04%
Per share
- EPS (fiscal year)
- 34.77
- Dividend per share
- 15.5
Technical
- RSI (14)
- 75.2
- 50-day moving average
- EGP 1,367.9
- 200-day moving average
- EGP 1,002.77
- Beta (1Y)
- -0.29
Shares
- Shares outstanding
- 5M
- Free float
- 29.84%
Source: company disclosures to the Egyptian Exchange via TradingView. Fiscal-year figures are as last reported; technical readings refresh with market data.